PATENT CLAIM ANALYSIS

Application Number: 16085140
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of DYRKIB in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease or disorder in an individual in need.

Claim (Index 7):
A method of inhibiting expression or activity of DYRK1B in a cell comprising contacting the cell with a compound comprising a DYRK1B specific inhibitor, thereby inhibiting expression or activity of DYRK1B in the cell.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.51613
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13660885', '15849017', '14552436', '14484638', '13623337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7625451362683261
- 35 USC 102 Novelty (BERT): 0.5550211206699026
- Combined Prediction Score: 0.7417927347084838
- Mean Citation Score: 301.037842
- Max Citation Score: 304.33423
- Similarity Product: 168.04972161131738

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test